RE:Breaking 90 centsYou are playing this stock for the wrong reason(s) and your biggest mistake is looking at it from a too short term time window. Ceapro stock price will likely go nowhere for the remainder of 2017 and that is a fact that one can already deduce due to the company having to operate the old plant and new plant simultaneously until Oct 2017. That will pressure earnings for the next two quarters at the very least. In addition, clinical studies for upcoming products in the pipeline will not be released until later this year and this is the quiet period for doldrums.
Some institutions and some retail investors will either grow frustrated or give up and dump the stock at the lows, and that is how it should be for a company with negative or uninspiring near term visibility. If you are willing to wait two to three years then this is absolutely the right time period to accumulate a decent position at bargain prices in hopes of a big payoff once the products in the development pipeline result in commercial sales.
But if keep looking at this day to day or week to week right now then you will be extremely disappointed and better off to move along.